The global nanotechnology drug delivery market is expected to grow at a CAGR of 12.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing prevalence of chronic diseases, rising demand for minimally invasive treatments, and growing adoption of nanotechnology in drug delivery systems.
Nanocrystals are expected to be the fastest-growing type segment in the global nanotechnology drug delivery market during the forecast period. Nanoparticles are also expected to grow at a significant rate due to their ability to penetrate deep into tissues and organs without causing any damage or side effects. Liposomes are also anticipated to witness significant growth owing to their ability for targeted release of drugs in specific areas within cells or tissues. Micelles are anticipated to witness moderate growth due to their ability for controlled release of drugs over an extended period of time with minimal side effects on healthy cells and tissues. Nanotubes are anticipated not only because they have high surface area but also because they can be used as carriers for other molecules that cannot be delivered by themselves such as proteins and peptides which can help treat various diseases like cancer, diabetes, arthritis etc,.
- Technological advancements in nanotechnology drug delivery systems that can be used to develop new drugs with improved efficacy and safety profiles.
Industry Growth Insights published a new data on “Nanotechnology Drug Delivery Market”. The research report is titled “Nanotechnology Drug Delivery Market research by Types (Nanocrystals, Nanoparticles, Liposomes, Micelles, Nanotubes, Others), By Applications (Neurology, Oncology, Cardiovascular/Physiology, Anti-inflammatory/Immunology, Anti-infective, Others), By Players/Companies Johnson & Johnson, Merck & Co, Roche, Bayer, Novartis Pharmaceuticals, Pfizer, Amgen, Celgene Corporation, Angiotech Pharmaceuticals, Capsulution Pharma, AlphaRx Inc., Calando Pharmaceuticals, Copernicus Therapeutics, Elan Corporation, Nanotherapeutics, PAR Pharmaceutical”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Nanotechnology Drug Delivery Market Research Report
By Type
Nanocrystals, Nanoparticles, Liposomes, Micelles, Nanotubes, Others
By Application
Neurology, Oncology, Cardiovascular/Physiology, Anti-inflammatory/Immunology, Anti-infective, Others
By Companies
Johnson & Johnson, Merck & Co, Roche, Bayer, Novartis Pharmaceuticals, Pfizer, Amgen, Celgene Corporation, Angiotech Pharmaceuticals, Capsulution Pharma, AlphaRx Inc., Calando Pharmaceuticals, Copernicus Therapeutics, Elan Corporation, Nanotherapeutics, PAR Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
240
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Nanotechnology Drug Delivery Market Report Segments:
The global Nanotechnology Drug Delivery market is segmented on the basis of:
Types
Nanocrystals, Nanoparticles, Liposomes, Micelles, Nanotubes, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Neurology, Oncology, Cardiovascular/Physiology, Anti-inflammatory/Immunology, Anti-infective, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Johnson & Johnson
- Merck & Co
- Roche
- Bayer
- Novartis Pharmaceuticals
- Pfizer
- Amgen
- Celgene Corporation
- Angiotech Pharmaceuticals
- Capsulution Pharma
- AlphaRx Inc.
- Calando Pharmaceuticals
- Copernicus Therapeutics
- Elan Corporation
- Nanotherapeutics
- PAR Pharmaceutical
Highlights of The Nanotechnology Drug Delivery Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Nanocrystals
- Nanoparticles
- Liposomes
- Micelles
- Nanotubes
- Others
- By Application:
- Neurology
- Oncology
- Cardiovascular/Physiology
- Anti-inflammatory/Immunology
- Anti-infective
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Nanotechnology Drug Delivery Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Nanotechnology drug delivery refers to the use of nanotechnology to improve the efficacy and safety of drugs. Nanotechnology can help reduce the size, weight, and toxicity of drugs while also increasing their effectiveness.
Some of the key players operating in the nanotechnology drug delivery market are Johnson & Johnson, Merck & Co, Roche, Bayer, Novartis Pharmaceuticals, Pfizer, Amgen, Celgene Corporation, Angiotech Pharmaceuticals, Capsulution Pharma, AlphaRx Inc., Calando Pharmaceuticals, Copernicus Therapeutics, Elan Corporation, Nanotherapeutics, PAR Pharmaceutical.
The nanotechnology drug delivery market is expected to register a CAGR of 12.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Nanotechnology Drug Delivery Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Nanotechnology Drug Delivery Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Nanotechnology Drug Delivery Market - Supply Chain
4.5. Global Nanotechnology Drug Delivery Market Forecast
4.5.1. Nanotechnology Drug Delivery Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Nanotechnology Drug Delivery Market Size (000 Units) and Y-o-Y Growth
4.5.3. Nanotechnology Drug Delivery Market Absolute $ Opportunity
5. Global Nanotechnology Drug Delivery Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Nanotechnology Drug Delivery Market Size and Volume Forecast by Type
5.3.1. Nanocrystals
5.3.2. Nanoparticles
5.3.3. Liposomes
5.3.4. Micelles
5.3.5. Nanotubes
5.3.6. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Nanotechnology Drug Delivery Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Nanotechnology Drug Delivery Market Size and Volume Forecast by Application
6.3.1. Neurology
6.3.2. Oncology
6.3.3. Cardiovascular/Physiology
6.3.4. Anti-inflammatory/Immunology
6.3.5. Anti-infective
6.3.6. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Nanotechnology Drug Delivery Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Nanotechnology Drug Delivery Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Nanotechnology Drug Delivery Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Nanotechnology Drug Delivery Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Nanotechnology Drug Delivery Demand Share Forecast, 2019-2026
9. North America Nanotechnology Drug Delivery Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Nanotechnology Drug Delivery Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Nanotechnology Drug Delivery Market Size and Volume Forecast by Application
9.4.1. Neurology
9.4.2. Oncology
9.4.3. Cardiovascular/Physiology
9.4.4. Anti-inflammatory/Immunology
9.4.5. Anti-infective
9.4.6. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Nanotechnology Drug Delivery Market Size and Volume Forecast by Type
9.7.1. Nanocrystals
9.7.2. Nanoparticles
9.7.3. Liposomes
9.7.4. Micelles
9.7.5. Nanotubes
9.7.6. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Nanotechnology Drug Delivery Demand Share Forecast, 2019-2026
10. Latin America Nanotechnology Drug Delivery Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Nanotechnology Drug Delivery Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Nanotechnology Drug Delivery Market Size and Volume Forecast by Application
10.4.1. Neurology
10.4.2. Oncology
10.4.3. Cardiovascular/Physiology
10.4.4. Anti-inflammatory/Immunology
10.4.5. Anti-infective
10.4.6. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Nanotechnology Drug Delivery Market Size and Volume Forecast by Type
10.7.1. Nanocrystals
10.7.2. Nanoparticles
10.7.3. Liposomes
10.7.4. Micelles
10.7.5. Nanotubes
10.7.6. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Nanotechnology Drug Delivery Demand Share Forecast, 2019-2026
11. Europe Nanotechnology Drug Delivery Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Nanotechnology Drug Delivery Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Nanotechnology Drug Delivery Market Size and Volume Forecast by Application
11.4.1. Neurology
11.4.2. Oncology
11.4.3. Cardiovascular/Physiology
11.4.4. Anti-inflammatory/Immunology
11.4.5. Anti-infective
11.4.6. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Nanotechnology Drug Delivery Market Size and Volume Forecast by Type
11.7.1. Nanocrystals
11.7.2. Nanoparticles
11.7.3. Liposomes
11.7.4. Micelles
11.7.5. Nanotubes
11.7.6. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Nanotechnology Drug Delivery Demand Share, 2019-2026
12. Asia Pacific Nanotechnology Drug Delivery Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Nanotechnology Drug Delivery Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Nanotechnology Drug Delivery Market Size and Volume Forecast by Application
12.4.1. Neurology
12.4.2. Oncology
12.4.3. Cardiovascular/Physiology
12.4.4. Anti-inflammatory/Immunology
12.4.5. Anti-infective
12.4.6. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Nanotechnology Drug Delivery Market Size and Volume Forecast by Type
12.7.1. Nanocrystals
12.7.2. Nanoparticles
12.7.3. Liposomes
12.7.4. Micelles
12.7.5. Nanotubes
12.7.6. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Nanotechnology Drug Delivery Demand Share, 2019-2026
13. Middle East & Africa Nanotechnology Drug Delivery Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Nanotechnology Drug Delivery Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Nanotechnology Drug Delivery Market Size and Volume Forecast by Application
13.4.1. Neurology
13.4.2. Oncology
13.4.3. Cardiovascular/Physiology
13.4.4. Anti-inflammatory/Immunology
13.4.5. Anti-infective
13.4.6. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Nanotechnology Drug Delivery Market Size and Volume Forecast by Type
13.7.1. Nanocrystals
13.7.2. Nanoparticles
13.7.3. Liposomes
13.7.4. Micelles
13.7.5. Nanotubes
13.7.6. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Nanotechnology Drug Delivery Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Nanotechnology Drug Delivery Market: Market Share Analysis
14.2. Nanotechnology Drug Delivery Distributors and Customers
14.3. Nanotechnology Drug Delivery Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Johnson & Johnson
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Merck & Co
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Roche
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Bayer
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Novartis Pharmaceuticals
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Pfizer
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Amgen
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Celgene Corporation
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Angiotech Pharmaceuticals
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Capsulution Pharma
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. AlphaRx Inc.
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Calando Pharmaceuticals
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Copernicus Therapeutics
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Elan Corporation
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Nanotherapeutics
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. PAR Pharmaceutical
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
